Skip to Content

Frequently Searched

Supported by

Up Close with Linvoseltamab

Last Updated: June 29, 2026

This section provides an overview of linvoseltamab-gcpt (LYNOZYFIC™).

Download PDF Here

Related Resources:

Patient Education Sheet

Linvoseltamab

Last Updated: 09/24/2025

Find Similar Resources:

Immunotherapy
Immunotherapy

Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)

Last Updated: 09/09/2026
 Immunotherapy

Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings

Last Updated: 07/01/2025
 Immunotherapy

Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure

Last Updated: 07/01/2025
 Immunotherapy

Example SOPs and Documents: Bispecific T-Cell Engager Ordering and REMS Compliance

Last Updated: 07/01/2025
Patient Education Sheet

Tocilizumab (Actemra)

Last Updated: 10/12/2026
 Patient Education Sheet

Pertuzumab (Perjeta), Paclitaxel (Taxol), Carboplatin, and Trastuzumab (Herceptin) (P-TCH)

Last Updated: 10/12/2026
 Patient Education Sheet

Camizestrant (Etcamah)

Last Updated: 10/12/2026
 Patient Education Sheet

Brentuximab Vedotin and CHP (Cyclophosphamide, Doxorubicin, Prednisone)

Last Updated: 10/12/2026
Last Updated: 10/14/2026